Filed: 8/11/2023ACC: 0001766721-23-000003
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $204.13M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$204.13M
Total AUM (reported)
23.12M
Total Shares
Allocation by class
COM$175.60M86.0%
SPONSORED ADS$23.58M11.6%
COM CL A$4.57M2.2%
CL A COM$379.9K0.2%
Portfolio Concentration
Top 3$149.40M73.2%
4–10$49.41M24.2%
11–25$5.32M2.6%
Top 3 weight
73.2%
Top 10 weight
97.4%
Voting Authority Distribution
Total shares with voting rights: 23.12M
Sole
Full voting authority
23.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$104.37M
51.13%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$23.58M
11.55%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$21.45M
10.51%
Sole
1.02M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$17.53M
8.59%
Sole
798.76K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$10.09M
4.94%
Sole
1.47M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$5.81M
2.85%
Sole
886.08K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$4.57M
2.24%
Sole
2.54M
Shared
0.00
None
0.00
Aclaris Theraputics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$4.51M
2.21%
Sole
434.45K
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$4.31M
2.11%
Sole
2.83M
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$2.59M
1.27%
Sole
1.21M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$1.84M
0.90%
Sole
1.04M
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$974.3K
0.48%
Sole
314.29K
Shared
0.00
None
0.00
Avrobio, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$959.4K
0.47%
Sole
1.01M
Shared
0.00
None
0.00
Aeglea Biotherapeutics Inc (AGLE)
SOLEShares1.69M
TypeSH
Market value$761.9K
0.37%
Sole
1.69M
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$406.9K
0.20%
Sole
288.57K
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$379.9K
0.19%
Sole
387.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $104.37M 51.13% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $23.58M 11.55% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $21.45M 10.51% | 1.02M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $17.53M 8.59% | 798.76K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $10.09M 4.94% | 1.47M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $5.81M 2.85% | 886.08K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $4.57M 2.24% | 2.54M | 0.00 | 0.00 |
Aclaris Theraputics Inc (ACRS)SOLE | COM | 434.45K | SH | $4.51M 2.21% | 434.45K | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $4.31M 2.11% | 2.83M | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $2.59M 1.27% | 1.21M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $1.84M 0.90% | 1.04M | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 314.29K | SH | $974.3K 0.48% | 314.29K | 0.00 | 0.00 |
Avrobio, Inc. (AVRO)SOLE | COM | 1.01M | SH | $959.4K 0.47% | 1.01M | 0.00 | 0.00 |
Aeglea Biotherapeutics Inc (AGLE)SOLE | COM | 1.69M | SH | $761.9K 0.37% | 1.69M | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $406.9K 0.20% | 288.57K | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $379.9K 0.19% | 387.65K | 0.00 | 0.00 |